Contribution of four common pulmonary function tests to diagnosis of patients with respiratory symptoms: A prospective cohort study

The Lancet Respiratory Medicine

Volumn 1, Issue 9, 2013, Pages 705-713

  Decramer, Marc ^a   Janssens, Wim ^a   Derom, Eric ^c   Joos, Guy ^c   Ninane, Vincent ^d   Deman, René ^e   Van Renterghem, Dirk ^f   Liistro, Giuseppe ^g   Bogaerts, Kris ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KU LEUVEN   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^e Groeninge Hospital   (Belgium)

^f Respiratory Division   (Belgium)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ARTICLE; ASTHMA; BELGIUM; BODY PLETHYSMOGRAPH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FATIGUE; FEMALE; HEART FAILURE; HEMOPTYSIS; HUMAN; HYPERVENTILATION; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROMUSCULAR DISEASE; OBESITY; PLEURA DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VASCULAR DISEASE; PULMONOLOGIST; RESPIRATORY TRACT DISEASE; SPIROMETRY; SPUTUM; SYSTEMIC SCLEROSIS; THORAX DISEASE; THORAX PAIN; UPPER RESPIRATORY TRACT OBSTRUCTION; VALIDATION PROCESS; WHEEZING;

EID: 84887043568     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70184-X     Document Type: Article

References (38)

1. Van den Bruel A, Gailly J, Devriese S Pulmonary function tests 2007. KCE report 60C (accessed July 3, 2013). https://kce.fgov.be/sites/default/files/page_documents/d20071027329.pdf.
2. Pratter MR, Curley FJ, Dubois J, Irwin RS Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 1989, 149:2277-2282.
3. Diagnosis and management of asthma Institute for Clinical Systems Improvement, (accessed July 3, 2013). https://www.icsi.org/_asset/rsjvnd/Asthma-Interactive0712.pdf.
4. Global strategy for asthma management and prevention. 2012 update Global Initiative for Asthma, (accessed July 3, 2013). http://www.ginasthma.org/local/uploads/files/GINA_Report_March13.pdf.
5. British guideline on the management of asthma Scottish Intercollegiate Guidelines Network, British Thoracic SocietyBritish Thoracic Society, (accessed July 3, 2013). http://www.brit-thoracic.org.uk/Portals/0/Guidelines/AsthmaGuidelines/PreviousAsthmaGuidelines/asthmaupdatenov05.pdf.
6. Long-term management of asthma. EBM Guidelines. Evidence-based medicine 2004, Finnish Medical Society Duodecim, Duodecim Medical Publications, Helsinki.
7. Diagnosis and management of chronic obstructive pulmonary disease Institute for Clinical Systems Improvement, (accessed July 3, 2013). https://www.icsi.org/_asset/yw83gh/COPD.pdf.
8. National guideline on management of chronic pulmonary disease in adults in primary and secondary care. Thorax 2004, 59(suppl 1):1-232. National Collaborating Centre for Chronic Conditions, National Institute for Health and Clinical ExcellenceNational Institute for Health and Clinical Excellence.
9. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2013 update Global Initiative for Chronic Obstructive Lung Disease, (accessed July 3, 2013). http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
10. Chronic obstructive pulmonary disease (COPD). EBM Guidelines. Evidence-based medicine 2004, Finnish Medical Society Duodecim, Wiley, Helsinki.
11. Miller A, Enright PL PFT interpretive strategies: American Thoracic Society/European Respiratory Society 2005 guideline gaps. Respir Care 2012, 57:127-133.
12. Ruppel GL What is the clinical value of lung volumes?. Respir Care 2012, 57:26-35.
13. Enright PL Spirometer + body box = VW beetle + Mercedes?. Respir Med 2011, 105:957-958.
14. Kanner RE, Renzetti AD, Stanish WM, Barkman HW, Klauber MR Predictors of survival in subjects with chronic airflow limitation. Am J Med 1983, 74:249-255.
15. Anthonisen NR, Wright EC, Hodgkin JE Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986, 133:14-20.
16. Hansen EF, Phanareth K, Laursen LC, Kok-Jensen A, Dirksen A Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1267-1271.
17. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003, 167:962-969.
18. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 171:591-597.
19. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N Development and first validation of the COPD Assessment test. Eur Respir J 2009, 34:648-654.
20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
21. Rosenberg E The 1995 update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor). Am J Respir Crit Care Med 1996, 154:265-266.
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993, 6(suppl):5-40.
23. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968.
24. Holm S A simple sequentially rejective multiple test procedure. Scand J Statist 1979, 6:65-70.
25. Liang K, Zeger S Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
26. Hewitt RS, Modrich CM, Medlicott T, Cowan JO, Taylor DR Supporting the diagnosis of non-specific respiratory symptoms in primary care: the role of exhaled nitric oxide measurement and spirometry. Prim Care Respir J 2008, 17:97-103.
27. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:53-83.
28. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003, 58:659-664.
29. Albert P, Agusti A, Edwards L, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax 2012, 67:701-708.
30. Boros PW, Enright PL, Quanjer PH, Borsboom GJ, Wesolowski SP, Hyatt RE Impaired lung compliance and DLCO but no restrictive ventilatory defect in sarcoidosis. Eur Respir J 2010, 36:1315-1322.
31. Jodoin G, Gibbs GW, Macklem PT, McDonald JC, Becklake MR Early effects of asbestos exposure on lung function. Am Rev Respir Dis 1971, 104:525-535.
32. De Troyer A, Yernault JC Inspiratory muscle force in normal subjects and patients with interstitial lung disease. Thorax 1980, 35:92-100.
33. Fulmer JD, Roberts WC, von Gal ER, Crystal RG Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979, 63:665-676.
34. Flaherty KR, King TE, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 2004, 170:904-910.
35. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011, 365:1567-1575.
36. Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012, 18:1711-1715.
37. Gulati M Diagnostic assessment of patients with interstitial lung disease. Prim Care Respir J 2011, 20:120-127.
38. Miller BH, Rosado-de-Christenson ML, McAdams HP, Fishback NF Thoracic sarcoidosis: radiologic-pathologic correlation. Radiographics 1995, 15:421-437.